New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - amoxicillin trihydrate 30.3 mg/ml equivalent to 25 mg/ml amoxicillin, on reconstitution;   - powder for oral suspension - 125 mg/5ml - active: amoxicillin trihydrate 30.3 mg/ml equivalent to 25 mg/ml amoxicillin, on reconstitution   excipient: carmellose sodium citric acid colloidal silicon dioxide erythrosine essence btm dm 7020a purified talc sodium benzoate sucrose - amoxicillin is indicated for the treatment of infections due to susceptible organisms. amoxicillin may be useful in instituting therapy prior to bacteriology; however bacteriological studies to determine the causative organisms and their sensitivity to amoxicillin should be determined. amoxicillin may be used for the prevention of bacteraemia, associated with procedures such as dental extraction, in patients at risk of developing bacterial endocarditis.

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - amoxicillin trihydrate 60.26 mg/ml equivalent to 50 mg/ml amoxicillin, on reconstitution;   - powder for oral suspension - 250 mg/5ml - active: amoxicillin trihydrate 60.26 mg/ml equivalent to 50 mg/ml amoxicillin, on reconstitution   excipient: carmellose sodium citric acid colloidal silicon dioxide erythrosine essence btm dm 7020a purified talc sodium benzoate sucrose - amoxicillin is indicated for the treatment of infections due to susceptible organisms. amoxicillin may be useful in instituting therapy prior to bacteriology; however bacteriological studies to determine the causative organisms and their sensitivity to amoxicillin should be determined. amoxicillin may be used for the prevention of bacteraemia, associated with procedures such as dental extraction, in patients at risk of developing bacterial endocarditis.

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - topiramate 15 mg - capsule - 15 mg - arrow - topiramate is indicated in adults and children 2 years and over:- as monotherapy in patients with newly diagnosed epilepsy - for conversion to monotherapy in patients with epilepsy - as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - topiramate 25mg - capsule - 25 mg - active: topiramate 25mg excipient: aniseed ethanol gelatin magnesium stearate opadry white 85f18378 povidone purified water saccharin sodium sugar spheres tekprint black sw-9008 titanium dioxide - arrow - topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy - for conversion to monotherapy in patients with epilepsy - as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - topiramate 50mg - capsule - 50 mg - active: topiramate 50mg excipient: aniseed ethanol gelatin magnesium stearate opadry white 85f18378 povidone purified water saccharin sodium sugar spheres tekprint black sw-9008 titanium dioxide - arrow - topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy - for conversion to monotherapy in patients with epilepsy - as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - alprazolam 0.25mg;   - tablet - 0.25 mg - active: alprazolam 0.25mg   excipient: colloidal silicon dioxide docusate sodium lactose monohydrate magnesium stearate maize starch microcrystalline cellulose povidone sodium benzoate sodium starch glycolate - for the treatment of anxiety and anxiety associated conditons in adults over 18 years old.

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - alprazolam 0.5mg;   - tablet - 0.5 mg - active: alprazolam 0.5mg   excipient: colloidal silicon dioxide docusate sodium lactose monohydrate magnesium stearate maize starch microcrystalline cellulose povidone purple pigment pb-20053 sodium benzoate sodium starch glycolate - for the treatment of anxiety and anxiety associated conditons in adults over 18 years old.

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - alprazolam 1mg;   - tablet - 1 mg - active: alprazolam 1mg   excipient: colloidal silicon dioxide docusate sodium indigo carmine lactose monohydrate magnesium stearate maize starch microcrystalline cellulose povidone sodium benzoate sodium starch glycolate - for the treatment of anxiety and anxiety associated conditons in adults over 18 years old.

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - alprazolam 2mg;   - tablet - 2 mg - active: alprazolam 2mg   excipient: colloidal silicon dioxide docusate sodium lactose magnesium stearate maize starch microcrystalline cellulose povidone sodium benzoate sodium starch glycolate

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - topiramate 25mg - film coated tablet - 25 mg - active: topiramate 25mg excipient: aniseed flavour 501007 bp0551 lactose magnesium stearate microcrystalline cellulose opadry white oy-b-28920 amb pregelatinised maize starch purified water saccharin sodium sodium starch glycolate - arrow - topiramate is indicated in adults and children 2 years** and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome. **arrow-topiramate tablet range cannot deliver lower doses required for younger paediatric patients .